#United States #New York #Class Action #Securities Fraud #Organon

Investors of Organon & Co. Invited to Participate in Class Action Lawsuit

Investors who have sustained losses while holding shares of Organon & Co. (NYSE: OGN) have been encouraged to contact the law firm Levi & Korsinsky, LLP regarding a pending class action lawsuit. This legal action arises from allegations of securities fraud that is claimed to have impacted investors between October 31, 2024 and April 30, 2025.

The Allegations

According to the lawsuit, the defendants in the case made overly optimistic statements about the financial health of Organon while allegedly concealing critical information about the company's financial priorities. Specifically, it is claimed that they misrepresented their commitment to returning value to shareholders through dividends while simultaneously prioritizing a substantial debt reduction strategy after acquiring Dermavant. This shift in focus reportedly led to a significant reduction in the company's quarterly dividend, from which many investors felt blindsided.

Following the release of this information, Organon's stock price experienced a dramatic decline. Closing at $12.93 on April 30, 2025, the stock plummeted to $9.45 by May 1, representing a loss of over 27% within a single day. This startling drop has raised concerns among shareholders who feel they were misled about the company’s strategies and future profitability.

What Investors Should Do

For those affected, there are critical deadlines approaching. The court will allow investors who suffered losses to request to be appointed as lead plaintiff until July 22, 2025. It is important to note that even if you do not wish to take on this role, you may still be part of the class and could potentially be eligible for compensation.

If you suffered financial damage during the specified timeframe, it’s crucial to act promptly. Levi & Korsinsky offers a no-cost option to participate in this legal action, meaning that shareholders can pursue their claims without upfront costs.

The Role of Levi & Korsinsky

Levi & Korsinsky comes with a robust track record, having secured hundreds of millions of dollars for investors over the past two decades. Their experience and reputation for handling complex securities litigation are consistent, with the firm being recognized multiple times as one of the top securities litigation firms in the United States, according to ISS Securities Class Action Services.

With a dedicated team of over 70 professionals, they prioritize the needs of their clients while navigating the intricacies of class action lawsuits. Investors are advised to reach out to Levi & Korsinsky for more information and assistance regarding the class action against Organon & Co.

For more details, affected shareholders may contact Joseph E. Levi, Esq. or simply visit their website for further assistance.

Contact Information:

• - Levi & Korsinsky, LLP

33 Whitehall Street, 17th Floor
New York, NY 10004
Email: [email protected]
Phone: (212) 363-7500
Fax: (212) 363-7171

The legal landscape is evolving, and this class action lawsuit may provide a pathway for investors to secure damages stemming from perceived corporate malfeasance. Act now if you believe you qualify for this action and join a collective movement aimed at regaining losses from Organon.